Fangda Li (@li_fangda) profile picture

PhD Candidate @Columbia University Irving Medical Center interested in hacking bacteria to deliver immunotherapy for cancer treatment.

New York, New Yok
Joined February 2019
Thrilled to share the primary focus of my PhD thesis work, now out in @ScienceMagazine today! We developed Trikines — engineered cytokines that reconfigure receptor complex assembly to reshape signaling directly in endogenous immune cells. doi.org/10.1126/science.adx9…
6
48
4
238
29,819
Fangda Li retweeted
New publication out today in @natBME 🎉led by @zsinger JPabon demonstrating engineered bacteria launch and control a virus. A very cool cooperative microbial strategy for cancer therapy. Congrats to all! in collab with @RiceLaboratory nature.com/articles/s41551-0…
2
17
4
51
6,292
TGF-β and IL-12 conversely orchestrate formation of CD103+ CD8 tumor-resident memory T cells to regulate response to therapeutic cancer vaccine cell.com/iscience/fulltext/S…
46
3
156
8,906
Review: Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives molecular-cancer.biomedcentr…
1
23
1
70
5,073
Leveraging #SyntheticBiology techniques, researchers have engineered a strain of #Salmonella that can stimulate mature tertiary lymphoid structures to augment antitumor immunity and shrink #ColorectalCancer tumors in mice. scim.ag/4jZrDFg
5
12
1,851
We previously showed that IFNg is required for CAR-T efficacy in solid tumors, but is it always good? Here, we show that IFNg limits CD28 CAR-T cells and that protection from this signal drives greater antitumor activity and durability. Enjoy! science.org/doi/10.1126/scit…
3
23
2
102
11,603
🚨 New Preprint 🚨 A continuous landscape of signaling encodes a corresponding landscape of CAR T cell phenotype How can we tune JAK/STAT signaling to create better immune cell therapies? doi.org/10.1101/2025.06.05.6…
12
55
7
184
20,306
Fangda Li retweeted
Excited to share a preprint of our latest study in collaboration w/ @tdanino's lab – synthetically engineered E. coli expressing CXCL13 synergizes with PD-1 blockade to amplify antitumor antibody responses and inhibit bladder cancer growth. @Columbia_MI biorxiv.org/content/10.1101/…
8
2
11
2,094
Excited to share my first author paper from my Ph.D.! I'd like to thank everyone in the Arpaia and Danino labs for their super human support!
10
173
Can table salt supercharge your immune system to fight cancer? According to research from CRI Lloyd J. Old STAR Dr. Enrico Lugli @luglilab, NaCl, or table salt, helps promote anti-cancer activity by preventing T cell exhaustion. Explore: bit.ly/3yWSAIk #CancerResearch
3
1
5
4,046
Very happy to share this new work on LAG3 and PD1. Has been a long road to (begin to) sort out how LAG3 functions in CD8 T cell exhaustion. Great work by Shin Ngiow and super collaboration (and 2 other great papers) with @Vignali_Lab and Dario Vignali cell.com/cell/abstract/S0092…
8
65
4
298
27,839
Bacteria in metastatic sites: Unveiling hidden players in cancer progression dlvr.it/T9Vrt5
82
3
250
31,725
Efficacy of cancer immunotherapies depends upon the formation of intratumoral immune triads between antigen-presenting cells and antigen-specific CD4+ and CD8+ T cells @Cancer_Cell PREVIEQW by @luglilab cell.com/cancer-cell/abstrac…
1
51
1
157
13,989
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors dlvr.it/T9L8n3
62
5
239
23,896
New @ScienceMagazine publication from @KalluriLab @MDAndersonNews Type I conventional dendritic cells facilitate immunotherapy in #PancreaticCancer science.org/doi/10.1126/scie… How is the tumor immune microenvironment of pancreatic cancer associated with pancreatitis (ptPDAC) different from cancer without preexisting pancreatitis (PDAC)? De novo inflammation facilitates the recruitment of type 1 conventional dendritic cells (cDC1s), which attenuate T cell infiltration by inducing tolerance to self antigens and preventing tissue damage. In ptPDAC, cDC1s are activated & induce tolerogenic CD4 T cell infiltration that promotes tumor progression. The cDC1 phenotype of ptPDAC can be co-opted by exogenous administration of DC vaccines, promoting response to immune checkpoint inhibitor therapy. This study highlights the importance of leveraging aspects of tumor promoting inflammation into a potential therapeutic modality.
34
121
13,703
Our new paper on “synpoptosis” circuits, led by the amazing @ShiyuXia, is now out: sciencedirect.com/science/ar… (1/3)
6
57
2
255
34,027
OK, this one is really meaningful for our whole team. Our preclinical paper on pan-RAS inhibition in pancreatic cancer is now online @Nature. Led by OliveLab student @ulawasko and Revolution Medicines colleagues JingJing Jiang and Mallika Singh. nature.com/articles/s41586-0…
19
55
9
218
30,857
Heart felt thanks to Jian, Suxin, Maggie and all the coauthors for persevering through a comprehensive study elucidating the importance of STING-cDC1 in antitumor immunity. Grateful to support from @IOTNmoonshot and @CPRITTexas scim.ag/5TL
6
1
32
2,099